AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Gigaset AG

Director's Dealing Feb 27, 2007

183_dirs_2007-02-27_6f6f9ca1-237b-497e-a74a-9a357fd39d31.html

Director's Dealing

Open in Viewer

Opens in native device viewer

News Details

Directors’ Dealings | 27 February 2007 18:37

DGAP-DD: ARQUES Industries AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. —————————————————————————— Details of the person subject to the disclosure requirement Last name: Löw First name: Dr. Dr. Peter Company: ARQUES Industries AG Function: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: Individual bearer share ISIN/WKN of the financial instrument: DE0005156004 Type of transaction: Sale Date: 23.02.2007 Price: 17.64 Currency: EUR No. of items: 3000000 Total amount traded: 52920000 Place: over the counter Explanation for publication: Ad hoc release according to para. 15 of the Securities Trading Law (WpHG) Change in executive board at ARQUES Industries Starnberg, February 27, 2007 – The current chief financial officer of the Starnberg-based equity investment company, ARQUES Industries AG (ISIN DE0005156004), Dr. Martin Vorderwülbecke, will succeed Dr. Peter Löw as executive board chairman on May 1, 2007. The appointment by the supervisory board is planned for the routine meeting on March 29, 2007. Dr. Löw will not extend his expiring five year contract and will withdraw into private life. The continuity in the company strategy and management is ensured by Dr. Vorderwülbecke taking over the position. Dr. Vorderwülbecke has been a member of the ARQUES executive board since July 1, 2004 and previously a member of the company’s supervisory board. With his withdrawal into private life, Dr. Löw has sold the bulk of his 14.14% share. The sale amounting to a total of 3 million shares (i.e. 12.36%) took place on February 23, 2007 at a price of EUR 17.64. Hereby the free float of the company increases to 100% since shares under 5% are not taken into consideration in the calculation. The shares were sold over the counter via an investment bank within a very short time to institutional investors in Germany and in Anglo-Saxon areas. ARQUES leaves the guidance for 2006 unchanged and affirms its prognoses for 2007. Information about the company with duty of publication Issuer: ARQUES Industries AG Münchner Str. 15a 82319 Starnberg Deutschland ISIN: DE0005156004 WKN: 515600 Index: SDAX End of Director’s Dealings Notification (c)DGAP 27.02.2007 The registration of this notification was carried out on http://www.dd-meldung.de or http://www.directors-dealings.de ID 1519

Talk to a Data Expert

Have a question? We'll get back to you promptly.